Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Peptide binding to the class Ib molecule, Qa-1b.

Z Kurepa and J Forman
J Immunol April 1, 1997, 158 (7) 3244-3251;
Z Kurepa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Forman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

We have analyzed the interaction of a nonameric peptide (Qdm) derived from the leader sequence of a MHC D region molecule with the class Ib molecule, Qa-1b. Using a direct binding assay with radiolabeled peptide on intact cells, we show specific binding of iodinated Qdm peptide to Qa-1b expressing cells. Specificity was confirmed by experiments in which the binding of iodinated peptide was blocked by unlabeled Qdm and not by control peptides. This allowed us to determine the on- and off-rate of peptide binding to Qa-1b, its binding affinity, and number of available peptide-binding sites per cell. Optimal binding occurs at 4 degrees C, and most of the binding to Qa-1b occurs within the first 10 min and peaks after 3 h. The dissociation of the peptide from cells has a t1/2 of approximately 10 h. The Kd is calculated between 0.2 and 1.1 x 10(-10) M, which is in the range or slightly higher than the Kd we measured for pMCMV to Ld (0.9 x 10(-10) M). The relatively high affinity of binding of the Qdm peptide and low dissociation rate could partially explain why a large portion of Qa-1b molecules are occupied with this single peptide species. We also changed each peptide residue to Ala or Gly to determine its effect on binding. Substitution of Leu at position 9 to Ala strongly reduced peptide binding, while changes at positions 2 (Met-->Ala) and 5 (Arg-->Ala) had a lesser effect. Binding to Qa-1b was completely abrogated with simultaneous Ala mutations at positions 2 and 9.

  • Copyright © 1997 by American Association of Immunologists

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

Log in using your username and password

Forgot your user name or password?
PreviousNext
Back to top

In this issue

The Journal of Immunology
Vol. 158, Issue 7
1 Apr 1997
  • Table of Contents
  • Table of Contents (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Peptide binding to the class Ib molecule, Qa-1b.
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Peptide binding to the class Ib molecule, Qa-1b.
Z Kurepa, J Forman
The Journal of Immunology April 1, 1997, 158 (7) 3244-3251;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Peptide binding to the class Ib molecule, Qa-1b.
Z Kurepa, J Forman
The Journal of Immunology April 1, 1997, 158 (7) 3244-3251;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606